Skip to Main Content
Mental Health & Behavioral Research, Phase III

In Patient Clinical Trial for the Treatment of Manic Episodes in Bipolar-I Disorder

What is the purpose of this trial?

The study drug KarXT is a new medication that combines two medicines into one treatment. It is designed to help treat psychiatric conditions, including bipolar mania. One part of the medication works in the brain to help improve symptoms, while the other part helps reduce unwanted side effects in the body. The second component mainly stays outside the brain, so it can block certain side effects without affecting how well the treatment works. This approach may offer a new way to treat bipolar mania, since many current medications work in similar ways and often have similar side effects.

Contact Information

For more information about this study, including how to volunteer, contact Kimberlee Forselius-Bielen

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/09/2026
  • Study IRB
    #2000040866